Philippe Van der Hofstadt is CEO of B & C Group, a European niche packaging & logistics company dedicated to clinical research and active on a global scale (www.bnc-group.com). After the degree of Pharmacist at Université Catholique de Louvain (UCL), Philippe worked at SGS Laboratoires Simon and Biopharma to become Industrial Pharmacist and did a third cycle in Pharmaceutical Engineering. He has worked as Junior Consultant in Regulatory Affairs and Clinical Research with Cogepharm & Pharmarisk in France and Belgium, Sales Manager with SmithKline Beecham Clinical Laboratories’ Central Laboratory (now QUEST) in Europe, and was General Manager of CRL-Medinet (Central Laboratory) in the Netherlands. In 1999, he started the expansion of B & C Group as a niche service provider in clinical research offering innovative & flexible Drug & kit packaging & warehousing, transport, biobanking and drug archiving solutions to Pharma & Biotech companies, CROs, Central Labs and Academic or Research Institutions. Philippe is active in several Professional Associations and is currently: President of BeCRO, the Belgian Association of CROs (www.becro.be) , member of EUCROF, the European CRO Federation (www.eucrof.eu), President of the VAPI-UPIP (Belgian Association of Industrial Pharmacists), Member of the BioWin Biobanking Working Group composed of representatives from commercial Biorepositories, the Belgian Cancer Registry, Universities, Research Laboratories, (Bio)Pharmaceutical and Diagnostic companies.
